Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis

American Journal of Gastroenterology

Volumn 99, Issue 2, 2004, Pages 292-298

  Browning, Jeffrey D ^b   Kumar, K Shiva ^b   Saboorian, M Hossein ^b   Thiele, Dwain L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; ETHNIC DIFFERENCE; FEMALE; GENETIC DIFFERENCE; GENETIC RISK; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

ADULT; AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; TEXAS;

EID: 1442301512     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04059.x     Document Type: Review

References (46)

1. Saunders JB, Walters JR, Davies AP, et al. A twenty year prospective study of cirrhosis. Br Med J 1981;282:263-6.
2. Kodali VP, Gordon SC, Silverman AL, et al. Cryptogenic liver disease in the United States: Further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol 1994;89:1836-9.
3. Bell SH, Beringer KC, Detre KM. An update of liver transplantation in the United States: Recipient characteristics and outcomes. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996.
4. Eigenbrodt ML, McCashland TM, Dy RM, et al. Heterozygous alpha-1 antitrypsin phenotypes in patients with end-stage liver disease. Am J Gastroenterol 1997;92:602-7.
5. Ku N, Gish R, Wright TL, et al. Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med 2001;344:1580-7.
6. Powell EE, Graham W, Cooklsey E, et al. The natural history of non-alcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
7. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-9.
8. Poonwala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000;32:689-92.
9. Struben VMD, Hespenheide EE, Caldwell S. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000;108:9-13.
10. Teli MR, James OFW, Burt AD, et al. The natural history of non-alcoholic fatty liver: A follow-up study. Hepatology 1995;22:1714-9.
11. Bacon BR, Farahvash MJ, Janney CG, et al. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994;107:1103-9.
12. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
13. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001;7:363-73.
14. Ong J, Younossi ZM, Reddy V, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001;7:797-801.
15. Caldwell SH, Harris DM, Patrie JT, et al. Is NASH under-diagnosed among African Americans? Am J Gastroenterol 2002;97:1496-500.
16. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health; 2001. NIH Publication 01-3670.
17. Harris MI, Regal KM, Cowre CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1998;21:518-24.
18. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemic of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA 2002;287:356-9.
20. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998.
21. Rochling FA, Jones WF, Chau K, et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. Hepatology 1997;25:478-83.
22. Marchesni G, Brizi M, Morsell-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5.
23. Marchesni G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
24. Abate N, Garg A, Peshock RM, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-93.
25. Banerji MA, Lebovitz HE. Insulin action in black Americans with NIDDM. Diabetes Care 1992;15:1295-302.
26. Banerji MA, Norin AJ, Chaiken RL, et al. HLA-DQ associations distinguish insulin-resistant and insulin-sensitive variants of NIDDM in black Americans. Diabetes Care 1993;16:429-33.
27. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study XII: Differences between Asian, Afro-Caribbean and White Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabetic Medicine 1994;11:670-7.
28. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: The Insulin Resistance Atherosclerosis Study. Diabetes 1997;46:63-9.
29. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
30. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.
31. Okosun IS, Liao Y, Rotimi CN, et al. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black, and Hispanic Americans. Ann Epidemiol 2000;10:263-70.
32. Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African American men than in white American men: Effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998;39:228-32.
33. Harris CL, Hewett-Emmett D, Bertin TK, et al. Origins of U.S. Hispanics: Implications for diabetes. Diabetes Care 1991;14:618-27.
34. Hilden M, Christoffersen P, Juhl E, et al. Liver histology in a "normal" population-Examination of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977;12:593-7.
35. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112-7.
36. Day CP, James OFW. Steatohepatitis: A tale of two "hits". Gastroenterology 1998;114:842-5.
37. Lavine J. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. J Pediatr 2000;136:734-8.
38. Caldwell SH, Swerdlow RH, Khan EM, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999;31:430-4.
39. Weltman MD, Farrell CG, Hall P, et al. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
40. Aoyama T, Peters JM, Iritani N, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR alpha). J Biol Chem 1998;273:5678-84.
41. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-9.
42. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 2001;125:1181-7.
43. Singh GK, Hoyert DL. Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: Trends and differential by ethnicity, socioeconomic status, and alcohol consumption. Hum Biol 2000;72:801-20.
44. Sievers ML, Nelson RG, Bennett PH. Adverse mortality experiences of a Southwestern American Indian community: Overall death rates and underlying causes of death in Pima Indians. J Clin Epidemiol 1990;43:1231-42.
45. Caetano R, Clark CL. Trends among alcohol related problems among whites, blacks, and Hispanics: 1984-1995. Alcohol Clin Exp Res 1998;22:534-8.
46. Raynard B, Balian A, Fallik D, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35:635-8.